1. Prekupec et al., Reviews Misuse of Novel Synthetic Opioids: A Deadly New Trend. Journal of Addiction Medicine, 2017.
2. Armenian et al., Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology, 2018.
3. Ringuette et al., DARK Classics in Chemical Neuroscience: Carfentanil. ACS Chemical Neuroscience, 2020.
4. Varshneya et al., Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated. Biochemical Pharmacology, 2022.
5. Hasegawa et al., Non-fentanyl-derived synthetic opioids emerging during recent years. Forensic Toxicology, 2022.
6. Ujvary et al., DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles. ACS Chemical Neuroscience, 2021.
7. Synthesis, Chemical Characterization, and µ-Opioid Receptor Activity Assessment of the
Emerging Group of 'Nitazene' 2-Benzylbenzimidazole Synthetic Opioids. ACS Chemical Neuroscience, 2021.
8. Vandeputte et al., Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid. Archives of Toxicology, 2022.
9. Palkovic et al., Nitazenes are potent mu-opioid receptor agonists with profound respiratory depression. FASEB Journal 2022.
10. Kwaku & Lindsley, DARK Classics in Chemical Neuroscience: U-47700. ACS Chemical Neuroscience, 2020.
11. Baumann et al., U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market. Brain Sciences, 2020.
12. Verougstraete et al., First Report on Brorphine: The Next Opioid on the Deadly New Psychoactive Substance Horizon? Journal of Analytical Toxicology, 2021.
13. Kennedy et al., Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias. Journal of Medicinal Chemistry, 2018.
14. World Health Organization, Critical Review Report: Brorphine. (2021)